Bibliography

Export 2842 results:
2015
Menis M, Forshee RA, Anderson SA, McKean S, Gondalia R, Warnock R, et al. Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012. Vox sanguinis//Vox Sang. 2015;108(3):251-61.
Chen Y, Huang X-, Wang Y, Liu K-, Chen H, Chen Y-, et al. Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors. Transfusion//Transfusion. 2015;55(8):2023-31.
Blumental S, Lambermont M, Heijmans C, Rodenbach M-, Kenz HE, Sondag D, et al. First Documented Transmission of Trypanosoma cruzi Infection through Blood Transfusion in a Child with Sickle-Cell Disease in Belgium. PLoS neglected tropical diseases//PLoS Negl Trop Dis. 2015;9(10):e0003986.
Gonzalez LM, Castro E, Lobo CA, Richart A, Ramiro R, Gonzalez-Camacho F, et al. First report of Babesia divergens infection in an HIV patient. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases// Int J Infect Dis. 2015;33:202-4.
Hoad VC, Speers DJ, Keller AJ, Dowse GK, Seed CR, Lindsay MD, et al. First reported case of transfusion-transmitted Ross River virus infection. The Medical journal of Australia// Med J Aust. 2015;202(5):267-70.
Annen K, Delaney M, Leitch D, Mast A. The health implications of low hemoglobin deferral in infrequent blood donors. //Transfusion. 2015;55(1):86-90.
Greco E, Minasi MG, Fiorentino F. Healthy Babies after Intrauterine Transfer of Mosaic Aneuploid Blastocysts. The New England journal of medicine//N Engl J Med. 2015;373(21):2089-90.
Quinti I, Pulvirenti F, Milito C, Granata G, Giovannetti G, La Marra F, et al. Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment. Transfusion. 2015;55:6.
Cooling L, Dake L, Haverty D, Mullis N, Ellis S, Shayman J, et al. A hemolytic anti-LKE associated with a rare LKE-negative, "weak P" red blood cell phenotype: alloanti-LKE and alloanti-P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens. //Transfusion. 2015;55(1):115-128.
Cooling L, Dake LR, Haverty D, Mullis N, Ellis S, Shayman J, et al. A hemolytic anti-LKE associated with a rare LKE-negative, "weak P" red blood cell phenotype: alloanti-LKE and alloanti-P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens. Transfusion//Transfusion. 2015;55(1):115-28.
Berg R, Jacob D, Fuellenhals E. Hemolytic events after the administration of lyophilized versus liquid immune globulin: an analysis of a single manufacturer’s safety database. Transfusion. 2015;55:7.
Nagamine Y, Hayashi T, Kato Y, Horiuchi Y, Tanahashi N. Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation. Internal medicine (Tokyo, Japan)// Intern Med. 2015;54(1):75-8.
Gupta S, Fenves A, Nance ST, Sykes DB, Dzik WS. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Transfusion//Transfusion. 2015;55(3):623-8.
Santos B, Portugal R, Nogueira C, Loureiro M. Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases. Transfusion//Transfusion. 2015;55(6 Pt 2):1394-8.
Pagano MB, Ness PM, Chajewski OS, King KE, Wu YY, Tobian AA. Hypotensive transfusion reactions in the era of prestorage leukoreduction. Transfusion//Transfusion. 2015;55(7):1668-74.
Verghese P, Schmeling D, Knight J, Matas A, Balfour H. The Impact of Donor Viral Replication at Transplant on Recipient Infections Posttransplant: A Prospective Study. //Transplantation. 2015;99(3):602-608.
Bharath V, Eckert K, Kang M, Chin-Yee IH, Hsia CC. Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center. Transfusion//Transfusion. 2015;55(11):2597-605.
Mulder H, Augustijn Q, van Woensel J, MD PD, Bos A, MD PD, et al. Incidence, risk factors, and outcome of transfusion-related acute lung injury in critically ill children: A retrospective study. //J Crit Care. 2015;30(1):55-59.
Refaai MA, Goldstein JN, Lee ML, Durn BL, Milling, Jr TJ, Sarode R. Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal. Transfusion. 2015;55(11):2722-9.
Seed CR, Maloney R, Kiely P, Bell B, Keller AJ, Pink J, et al. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme. Vox sanguinis// // Vox Sang. 2015;108(2):113-22.
Kramer K. An inventory of concerns behind blood safety policies in five Western countries. Transfusion. 2015;55(12):16.
Dodd RY, Foster GA, Stramer SL. Keeping Blood Transfusion Safe From West Nile Virus: American Red Cross Experience, 2003 to 2012. Transfus Med Rev. 2015;29(3):53.
Abbott IJ, Papadakis G, Kaye M, Opdam H, Hutton H, Angus PW, et al. Laboratory identification of donor-derived coxsackievirus b3 transmission. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons// // Am J Transplant. 2015;15(2):555-9.
Abbott I., Papadakis G., Kaye M., Opdam H., Hutton H., Angus P., et al. Laboratory Identification of Donor-Derived Coxsackievirus B3 Transmission. //Am J Transplant. 2015;15(2):555-559.
Boonyasampant M, Weitz I, Kay B, Boonchalermvichian C, Liebman H, Shulman I. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion. 2015.

Pages